Cadila Healthcare
Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec
Stocks to watch: RCFL, Tata Motors, RIL, BEML, Cadila Health, Adani Green
Cadila Healthcare completes phase-2 trial of Hepatitis C drug for Covid-19
Indices rally for 5th straight day, Sensex up 553 pts; RIL, financials gain
Cadila Healthcare rallies 9% on strong September quarter results

Govt to prioritise Covid-19 vaccine for front line health workers: Report
Cadila scouts partners to ramp up Covid vaccine production by 50 to 70 mn
Cadila: Rebound in domestic formulations to add to US sales, drive earnings
Cadila Healthcare rises 4% on launch of pressurized Metered Dose Inhaler
Covid-19 prescription: Pharma players shift their focus over the counter

Covid-19: At Rs 2,800 per dose, Zydus launches cheapest remdesivir brand
Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India
US-led growth helps Cadila post steady Q1 show even as India biz falters
Cadila Healthcare slips 4.5% from day's high post June quarter results
Nifty view and stock picks by Anand Rathi: Buy Tata Consumer, Sell Escorts
Aarti Drugs to Tata Comm: Earnings rise for 15 firms in Covid-19 economy
Here's a Bull Spread strategy for Cadila Healthcare by HDFC Securities
Six Indian drug firms that are doing serious business in coronavirus times
Cadila gains 5% on DGCI nod for clinical trials of Covid-19 vaccine
Cadila's renewed focus on India biz, Covid-19 opportunities lend confidence